Richard P. Slaughter Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NEOS Enhanced Income 1-3 Month T-Bill ETF
CSHI
|
+$14.6M |
| 2 |
iShares Russell Top 200 Growth ETF
IWY
|
+$14.6M |
| 3 |
iShares Russell Top 200 Value ETF
IWX
|
+$7.54M |
| 4 |
Angel Oak UltraShort Income ETF
UYLD
|
+$3.97M |
| 5 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
|
+$11.5M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$3.81M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$3.41M |
| 4 |
BP
BP
|
+$3.26M |
| 5 |
Diodes
DIOD
|
+$2.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 6.69% |
| 2 | Technology | 6.4% |
| 3 | Healthcare | 3.98% |
| 4 | Energy | 3.53% |
| 5 | Industrials | 3.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.4B
| – | – |
-8,097
| Closed | -$411K |
|
152
Microchip Technology
MCHP
$44.4B
| – | – |
-3,055
| Closed | -$245K |
|
153
Moderna
MRNA
$23.6B
| – | – |
-18,901
| Closed | -$1.26M |
|
154
iShares Short Maturity Bond ETF
NEAR
$4.88B
| – | – |
-10,088
| Closed | -$517K |
|
155
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
| – | – |
-29,786
| Closed | -$708K |
|
|
156
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
$1.04B
| – | – |
-237,798
| Closed | -$11.5M |
|
Similar funds
Richard P. Slaughter Associates's Q4 2024 Portfolio in Review
As of Q4 2024, Richard P. Slaughter Associates held 156 positions worth $447M, up 3.6% from $431M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Richard P. Slaughter Associates deployed $22.7M of net new capital in Q4 2024, opening 8 new positions and adding to 55 existing holdings. Its largest new stake was iShares Russell Top 200 Growth ETF: 63,558 shares worth $15M.
By sector, the portfolio is most concentrated in Financials at 6.7% of assets, up from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $3.81M trimmed.
- Richard P. Slaughter Associates's largest Q4 2024 buy was iShares Russell Top 200 Growth ETF: 63,558 shares worth $15M.
- Richard P. Slaughter Associates added most to NEOS Enhanced Income 1-3 Month T-Bill ETF in Q4 2024, an estimated $14.6M increase.
- Richard P. Slaughter Associates's biggest Q4 2024 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $3.81M.
- Richard P. Slaughter Associates fully exited BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF in Q4 2024, selling an estimated $11.5M.
- Richard P. Slaughter Associates's ten largest holdings make up 45% of its $447M portfolio in Q4 2024.
- Richard P. Slaughter Associates opened 8 new positions and closed 12 in Q4 2024.
- Richard P. Slaughter Associates's portfolio value rose 3.6% quarter-over-quarter to $447M.
Based on Richard P. Slaughter Associates's 13F filing for Q4 2024, filed 14 Jan 2025.